View Older Stories View More Recent Stories
-
Synchronoss to Participate in the Roth Capital Technology Virtual Investor Event
-
GP Strategies (GPX) PT Raised to $15 at Roth Capital, Following Earnings
-
Entasis Therapeutics (ETTX) PT Lowered to $8 at Roth Capital, Following Earnings
-
BioMedNewsBreaks – Turning Point Therapeutics Inc. (NASDAQ: TPTX) Secures $460M in Underwritten Public Offering
-
Digi International Announces Schedule for November Investor Conferences
-
UPDATE: Roth Capital Upgrades Resideo Technologies (REZI) to Buy
-
Inseego Corp. (INSG) Likely to Face Transition Issues, Roth Capital Reiterates Neutral
-
Cambium Networks Reports Third Quarter 2020 Financial Results
-
Lakeland Industries to Participate in Upcoming Virtual Investor Events
-
Broadwind Energy (BWEN) PT Lowered to $4 at Roth Capital
-
Roth Capital Starts Intrepid Potash (IPI) at Buy
-
fuboTV (FUBO) Gets Glowing Reception on Wall Street as 5 Firms Say 'Buy'
-
Torchlight and Metamaterial Extend LOI, Continue Work Towards Definitive Agreement
-
SolarEdge Technologies (SEDG) PT Raised to $300 but Roth Capital Warns a Sell the News Event may be Coming
-
Roth Capital Starts fuboTV (FUBO) at Buy
-
UPDATE: Roth Capital Reinstates TransAct Technologies (TACT) at Buy
-
UPDATE: Roth Capital Maintains Universal Display (OLED) at Neutral (Correction)
-
Shopify (SHOP) Sees Record Bump in Merchant Ads but Tough Comps in '21 Keep Roth Capital at Neutral
-
Eastside Distilling, Inc. Announces Letter of Intent to Divest its Redneck Riviera Spirits® Business, gives preliminary guidance for Third Quarter results and key strategic objectives for sustainable
-
Turning Point Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Common Stock
-
Turning Point Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Common Stock
-
Inuvo to Participate in the ROTH Capital Technology Virtual Conference on November 11-12
-
QuickLogic to Participate in Upcoming Investor Events
-
Generac Holdings (GNRC) PT Raised to $260 at Roth Capital as Revenue Tops High Expectations
-
Omeros Participates in Investor Conference Focused on COVID-19 Therapeutics in Development
-
First Solar (FSLR) PT Raised to $110 at Roth Capital in a Quarter with Many Moving Parts
-
Humanigen to Present at Upcoming Investor Conferences
-
Ampio Pharmaceuticals, Inc. to Present at the ROTH Capital Healthcare Event "COVID-19 Therapeutics in Development"
-
CohBar to Participate at ROTH Capital COVID-19 Therapeutics in Development Event
-
CohBar to Participate at ROTH Capital COVID-19 Therapeutics in Development Event
-
Hepion Pharmaceuticals to Present on Therapeutic Approaches to COVID-19 and NASH at Two Virtual Conferences on October 28 and 29, 2020
-
Moleculin to Participate in Panel at ROTH Capital's "COVID-19 Therapeutics in Development" Healthcare Event
-
aTyr Pharma to Participate in ROTH Capital Partners Webinar on COVID-19 Therapeutics in Development on October 28th
-
Syros Pharmaceuticals (SYRS) PT Raised to $20 at Roth Capital After Phase 1 Data Announcement
-
Turning Point Therapeutics Inc. (TPTX) Prices 4.6M Share Common Offering at $87/Sh
-
/C O R R E C T I O N -- Aridis Pharmaceuticals, Inc./
-
Aridis Pharmaceuticals to Present at the ROTH Capital Partners 2020 MedTech Innovation Forum on a COVID-19 Panel
-
Turning Point Therapeutics Announces Pricing of $400 Million Public Offering of Common Stock
-
Turning Point Therapeutics Announces Pricing of $400 Million Public Offering of Common Stock
-
DURECT Corporation to Participate in the ROTH Capital Partners Healthcare Event "Covid-19 Therapeutics in Development"
-
InvestorNewsBreaks – TransAct Technologies Incorporated (NASDAQ: TACT) Secures $10M Through Underwritten Public Offering
-
Ampio Presents at Roth Capital Partners 2020 MedTech Innovation Forum Focusing on COVID-19 Clinical Trial Activities
-
Fathom Holdings Inc. (FTHM) PT Raised to $23.50 at Roth Capital
-
Turning Point Therapeutics Inc. (TPTX) Announces Commencement of $400M Public Offering of Common Stock
-
Turning Point Therapeutics Announces Commencement of Public Offering of Common Stock
-
Turning Point Therapeutics Announces Commencement of Public Offering of Common Stock
-
UPDATE: Roth Capital Downgrades Daqo New Energy (DQ) to Neutral
-
UPDATE: Roth Capital Upgrades First Solar (FSLR) to Buy
-
Piedmont Announces Closing of Public Offering and Full Exercise of Underwriters’ Over-Allotment Option
-
American Superconductor (AMSC) Prices 3.67M Share Offering at $15/Sh

